Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis.

Bierkens M, Krijgsman O, Wilting SM, Bosch L, Jaspers A, Meijer GA, Meijer CJ, Snijders PJ, Ylstra B, Steenbergen RD.

Genes Chromosomes Cancer. 2013 Jan;52(1):56-68. doi: 10.1002/gcc.22006. Epub 2012 Sep 14.

PMID:
22987659
2.

Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.

Li B, Hu Y, Ye F, Li Y, Lv W, Xie X.

Int J Gynecol Cancer. 2010 May;20(4):597-604. doi: 10.1111/IGC.0b013e3181d63170.

PMID:
20442590
3.

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.

Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, Snijders PJ.

J Natl Cancer Inst. 2004 Feb 18;96(4):294-305.

PMID:
14970278
4.

Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.

Steenbergen RD, Ongenaert M, Snellenberg S, Trooskens G, van der Meide WF, Pandey D, Bloushtain-Qimron N, Polyak K, Meijer CJ, Snijders PJ, Van Criekinge W.

J Pathol. 2013 Sep;231(1):53-62. doi: 10.1002/path.4210. Epub 2013 Jul 8.

PMID:
23674368
5.

Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.

Wilting SM, Verlaat W, Jaspers A, Makazaji NA, Agami R, Meijer CJ, Snijders PJ, Steenbergen RD.

Epigenetics. 2013 Feb;8(2):220-8. doi: 10.4161/epi.23605. Epub 2013 Jan 16.

6.

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

Wilting SM, van Boerdonk RA, Henken FE, Meijer CJ, Diosdado B, Meijer GA, le Sage C, Agami R, Snijders PJ, Steenbergen RD.

Mol Cancer. 2010 Jun 26;9:167. doi: 10.1186/1476-4598-9-167.

7.

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.

Bierkens M, Wilting SM, van Wieringen WN, van de Wiel MA, Ylstra B, Meijer CJ, Snijders PJ, Steenbergen RD.

BMC Cancer. 2012 Jan 24;12:36. doi: 10.1186/1471-2407-12-36.

8.

Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.

de Wilde J, Wilting SM, Meijer CJ, van de Wiel MA, Ylstra B, Snijders PJ, Steenbergen RD.

Int J Cancer. 2008 Feb 15;122(4):877-88.

9.

DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.

Melsheimer P, Vinokurova S, Wentzensen N, Bastert G, von Knebel Doeberitz M.

Clin Cancer Res. 2004 May 1;10(9):3059-63.

10.

Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis.

Thomas LK, Bermejo JL, Vinokurova S, Jensen K, Bierkens M, Steenbergen R, Bergmann M, von Knebel Doeberitz M, Reuschenbach M.

Eur J Cancer. 2014 Jan;50(1):85-98. doi: 10.1016/j.ejca.2013.08.022. Epub 2013 Sep 17. Review.

PMID:
24054023
11.

High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies.

Fiedler M, Müller-Holzner E, Viertler HP, Widschwendter A, Laich A, Pfister G, Spoden GA, Jansen-Dürr P, Zwerschke W.

FASEB J. 2004 Jul;18(10):1120-2. Epub 2004 May 20.

PMID:
15155561
12.

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.

Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, van Wieringen WN, Meijer GA, Kenter GG, Yi Y, le Sage C, Agami R, Meijer CJ, Steenbergen RD.

Oncogene. 2013 Jan 3;32(1):106-16. doi: 10.1038/onc.2012.20. Epub 2012 Feb 13.

PMID:
22330141
13.

A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.

Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, Hoeckel M, von Knebel Doeberitz M.

Oncogene. 2003 Jun 19;22(25):3977-84.

PMID:
12813471
14.

[Relationship among HPV16 infection and Expression of hTERT, p21waf1, Ki67 in cervical intraepithelial neoplasias and squamous cell carcinomas of cervix uteri].

Zhao FX, Sun RF, Wang JF, Chen XW.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2005 Dec;19(4):370-4. Chinese.

PMID:
16415998
16.

E2F-Rb complexes assemble and inhibit cdc25A transcription in cervical carcinoma cells following repression of human papillomavirus oncogene expression.

Wu L, Goodwin EC, Naeger LK, Vigo E, Galaktionov K, Helin K, DiMaio D.

Mol Cell Biol. 2000 Oct;20(19):7059-67.

17.
18.

Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells.

Vazquez-Ortiz G, García JA, Ciudad CJ, Noé V, Peñuelas S, López-Romero R, Mendoza-Lorenzo P, Piña-Sánchez P, Salcedo M.

Int J Gynecol Cancer. 2007 Mar-Apr;17(2):484-91. Epub 2007 Feb 14.

PMID:
17309674
19.

MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20.

Yao T, Lin Z.

Biochim Biophys Acta. 2012 Feb;1822(2):248-60. doi: 10.1016/j.bbadis.2011.09.018. Epub 2011 Oct 7.

20.

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.

Li BH, Zhou JS, Ye F, Cheng XD, Zhou CY, Lu WG, Xie X.

Eur J Cancer. 2011 Sep;47(14):2166-74. doi: 10.1016/j.ejca.2011.04.037. Epub 2011 Jun 1.

PMID:
21636267

Supplemental Content

Support Center